Literature DB >> 25197459

Draft genome sequences and description of Lactobacillus rhamnosus strains L31, L34, and L35.

Prapaporn Boonma1, Jennifer K Spinler2, Xiang Qin3, Chutima Jittaprasatsin1, Donna M Muzny3, Harsha Doddapaneni3, Richard Gibbs3, Joe Petrosino4, Somying Tumwasorn5, James Versalovic6.   

Abstract

Lactobacillus rhamnosus is a facultative, lactic acid bacterium in the phylum Firmicutes. Lactobacillus spp. are generally considered beneficial, and specific strains of L. rhamnosus are validated probiotics. We describe the draft genomes of three L. rhamnosus strains (L31, L34, and L35) isolated from the feces of Thai breastfed infants, which exhibit anti-inflammatory properties in vitro. The three genomes range between 2.8 - 2.9 Mb, and contain approximately 2,700 protein coding genes.

Entities:  

Keywords:  Lactobacillus rhamnosus; anti-inflammatory; comparative genomics; lactic acid bacteria; probiotics

Year:  2014        PMID: 25197459      PMCID: PMC4148986          DOI: 10.4056/sigs.5048907

Source DB:  PubMed          Journal:  Stand Genomic Sci        ISSN: 1944-3277


Introduction

is the largest of three genera within the family , and belongs to one of the dominant phyla, , in the human microbiome [1]. spp. are naturally isolated from fermented foods [2], and are key members of the human microbiota, reviewed in [3]. In humans, they colonize the oral cavity, gastrointestinal and urogenital tracts, and breast milk [4]. As a whole, this genus is beneficial to humans, possesses many probiotic traits, and is rarely associated with disease. The human-intestinal isolate, strain GG, is one of the most studied and applied probiotics. Research has shown that GG can modulate host immunity in vitro by decreasing inflammatory cytokine production from various eukaryotic cell lines [5,6], induces intestinal mucin gene expression subsequently inhibiting pathogen adherence in vitro [7]; and attenuates in vitro barrier dysfunction induced by inflammatory cytokines [8]. Here we present the draft genomes and classification summary of three potential probiotic strains L31, L34, and L35 isolated from the feces of Thai breastfed infants [9]. Genome sequencing and comparisons of L31, L34, and L35 with the species type-strain, GG should help researchers identify distinguishing genetic features important for specific probiotic traits.

Classification and features

Within the phylum , the family contains three genera: and ; being the largest with latest estimates ranging between 227-230 species (http://www.dsmz.de/bacterial-diversity/prokaryotic-nomenclature-up-to-date/prokariotic-nomenclature-up-to-date.html) [10]. Members of are gram-positive, non-motile, anaerobic, lactic-acid-producing bacilli that are divided into three fermentation groups: A) obligately homofermentative, B) facultatively heterofermentative, and C) obligately heterofermentative [4]. resides in fermentation group B and is distinct from the three major phylogenetic groups based on 16S rRNA gene sequence (, , and groups) [4]. strains L31, L34, and L35 are phylogenetically similar to GG and maintain a distinctive 16S rRNA gene-based phyologeny from the three major groups (Figure 1). The basic characteristics of L31, L34, and L35 are summarized in Table 1.
Figure 1

The phylogenetic tree represents the relationships of strains L31, L34, and L35 with respect to several members of the genus . The strains and their corresponding GenBank accession numbers for 16S rRNA genes are: L. rhamnsosus strain GG, NC_013198, strain CECT 5713, NC_017481, strain ATCC 27782, NC_015975, strain JCM 1112, NC_010609, strain CECT 5716, NC_017465, strain NCC 533, NC_005362, strain ATCC 11842, NC_008054, strain NCFM, NC_006814. Full-length 16S rRNA gene sequences were aligned using ClustalW, and phylogenetic inferences were obtained using the maximum-likelihood method within the MEGA 5.2 software [11] with 1,000 bootstraps. strain 6051 HGW (NC_020507) was used as an outgroup.

Table 1

Classification and general features of strains L31, L34, and L35 according to the MIGS recommendation

MIGS ID        Property        Term       Evidence codea
        Classification        Domain Bacteria       TAS [12]
        Phylum Firmicutes       TAS [13-15]
        Class Bacillus       TAS [16-18]
        Order Lactobacillales       TAS [19,20]
        Family Lactobacillaceae       TAS [16,21]
        Genus Lactobacillus       TAS [16,22-26]
        Species Lactobacillus rhamnosus       TAS [27]
        Strains L31, L34, and L35       IDA
        Gram stain        Positive       IDA
        Cell shape        Rod-shaped       IDA
        Motility        Non-motile       NAS
        Sporulation        Non-sporulating       NAS
        Temperature range        Mesophile       NAS
        Optimum temperature        37°C       IDA
        Carbon source        Glucose       NAS
        Energy source        Lactose, glucose and other sugars       NAS
MIGS-6        Habitat        Human GI Tract       NAS
MIGS-22        Oxygen        Facultative anaerobes       IDA
MIGS-15        Biotic relationship        Symbiotic relationship       NAS
MIGS-14        Pathogenicity        Nonpathogenic; potential probiotic       IDA
        Biosafety level        1       NAS
        Isolation        Infant Feces       IDA
MIGS-4        Geographic location        Bangkok, Thailand       IDA
MIGS-5        Sample collection time        Not reported
MIGS-4.1        Latitude        13° 45’N       IDA
MIGS-4.2        Longitude        100° 35’E       IDA
MIGS-4.4        Altitude        Not reported       NAS

a) Evidence codes – IDA: Inferred from Direct Assay; TAS: Traceable Author Statement (i.e., a direct report exists in the literature); NAS: Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project [28].

The phylogenetic tree represents the relationships of strains L31, L34, and L35 with respect to several members of the genus . The strains and their corresponding GenBank accession numbers for 16S rRNA genes are: L. rhamnsosus strain GG, NC_013198, strain CECT 5713, NC_017481, strain ATCC 27782, NC_015975, strain JCM 1112, NC_010609, strain CECT 5716, NC_017465, strain NCC 533, NC_005362, strain ATCC 11842, NC_008054, strain NCFM, NC_006814. Full-length 16S rRNA gene sequences were aligned using ClustalW, and phylogenetic inferences were obtained using the maximum-likelihood method within the MEGA 5.2 software [11] with 1,000 bootstraps. strain 6051 HGW (NC_020507) was used as an outgroup. a) Evidence codes – IDA: Inferred from Direct Assay; TAS: Traceable Author Statement (i.e., a direct report exists in the literature); NAS: Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project [28]. The colony and Gram stain morphology of strains L31, L34, and L35 are each depicted in Figure 2. Supernatants from L34 and L35, both isolated from the same 40 day old female, suppress LPS-induced TNF-α production by THP-1 cells [9] and C. difficile-induced IL-8 production by HT-29 cells [29]. Similarly, strain L31, isolated from a 39 day old female, suppresses LPS-induced TNF-α production by THP-1 cells, however does not suppress C. difficile-induced IL-8 production by HT-29 cells [29]. All three strains are resistant to two drugs commonly used to treat C. difficile infection in humans, vancomycin and metronidazole (MIC90 >256µg/mL for each), but are susceptible to low concentrations (MIC90 = 2µg/mL) of the newest antibiotic targeting C. difficile, fidaxomicin. These strain-specific characteristics suggest L34 and L35 are potential probiotic candidates for either preventing or treating C. difficile disease.
Figure 2

Colony morphology and Gram stains of strains L31, L34, and L35. strains were cultured anaerobically on MRS agar at 37°C for 48 hr. Gram stains were carried out using standard methods, and images were taken under oil emersion at 100× magnification.

Colony morphology and Gram stains of strains L31, L34, and L35. strains were cultured anaerobically on MRS agar at 37°C for 48 hr. Gram stains were carried out using standard methods, and images were taken under oil emersion at 100× magnification.

Genome sequencing information

Genome project history

strains L31, L34, and L35 were selected for sequencing based on the properties described above. The draft genome sequence for each strain was finished in October 2012. The Whole Genome Shotgun projects for L31, L34, and L35 have been deposited at DDBJ/EMBL/GenBank under the accession numbers AYTQ00000000, AYTR00000000, and AYTP0000000, respectively. The versions described in this paper are AYTQ01000000, AYTR01000000, and AYTP0100000, respectively. The genome projects for L31, L34, and L35 are listed in the Genome OnLine Database (GOLD) [30] as projects Gi0036900, Gi0036903, and Gi0036905, respectively. Genome sequencing and assembly was completed at Baylor College of Medicine’s Human Genome Sequencing Center (BCM-HGSC). Automatic annotation was performed using the DOE-JGI Microbial Annotation Pipeline (DOE-JGI MAP). Table 2 shows the project information and its association with MIGS version 2.0 compliance [31].
Table 2

Project information

MIGS ID      L31      L34       L35
MIGS ID      Property      Term      Term       Term
MIGS-31      Finishing quality      Standard Draft      Standard Draft       Standard Draft
MIGS-28      Libraries used      8 kb, mate paired library      8 kb, mate paired library       8 kb, mate paired library
MIGS-29      Sequencing platforms      454 GS FLX      454 GS FLX       454 GS FLX
MIGS-31.2      Fold coverage      23×      29×       26×
MIGS-30      Assemblers      Newbler v2.5.3      Newbler v2.5.3       Newbler v2.5.3
MIGS-32      Gene calling method      Prodigal      Prodigal       Prodigal
      Genome Database release      March 1, 2014      March 1, 2014       March 1, 2014
      GenBank ID      AYTQ00000000      AYTR00000000       AYTP00000000
      GenBank Date of Release      March 1, 2014      March 1, 2014       March 1, 2014
      GOLD ID      Gi0036900      Gi0036903       Gi0036905
      Project relevance      Potential probiotic      Potential probiotic       Potential probiotic

Growth conditions and DNA isolation

strains L31, L34, and L35 were routinely cultured in an anaerobic chamber (Concept Plus, Ruskinn Technology, UK) (10% CO2, 10% H2, and 80% N2) for 24-48 h at 37°C in de Man, Rogosa, Sharpe (MRS) medium (Oxoid, England). For genomic DNA isolation, cultures were adjusted to an OD600 of 0.1 and incubated anaerobically at 37°C for 8 h. Bacterial pellets were collected by centrifugation and the DNA was extracted using QIAGEN Genomic-tip100/G columns (Qiagen, Germany) according to the manufacturer’s instructions. DNA quality was analyzed by agarose gel electrophoresis, and concentrations were determined by fluorescence using the Qubit™ DNA Assay (Life Technologies, USA).

Genome sequencing and assembly

The genomes of strains L31, L34, and L35 were sequenced at the BCM-HGSC, USA on a Roche 454 GS FLX sequencing platform. A fragment sequencing approach was implemented using 8 kb libraries generated by long insert mate paired construction, as detailed in the Human Microbiome Project Reference Genome Project protocol [32] to about 23× (254,342 reads), 29× (283,036 reads), and 26× (249,176 reads) sequence depth coverage, respectively, with an estimated read alignment error rate of 0.84%. The sequence data were assembled using the Newbler assembler version 2.5.3. The final assemblies resulted in 67 (L31), 51 (L34), and 51 (L35) contigs generating corresponding genome sizes of 2.8, 2.9, and 2.9 Mb in 3, 3, and 4 scaffolds.

Genome annotation

Open Reading Frames (ORFs) were predicted using Prodigal [33,34] as part of the Oak Ridge National Laboratory genome annotation pipeline, followed by a round of manual curation using the JGI GenePRIMP pipeline [35]. The predicted protein coding sequences (CDSs) were translated and searched against the National Center for Biotechnology Information (NCBI) non-redundant database, UniProt, TIGRFam, Pfam, PRIAM, KEGG, COG, and InterPro databases [35]. These data sources were combined to assert a product description for each predicted protein. Additional gene prediction analysis and manual functional annotation was performed with the Integrated Microbial Genomes Expert Review (IMG-ER) platform [36]. Non-coding genes and miscellaneous features were predicted using tRNAscan-SE [37], RNAMMer [38], Rfam [39], TMHMM [40], and signalP [41].

Genome properties

The properties and statistics for the three genomes are summarized in Table 3. The distribution of genes into COG functional categories for each genome is detailed in Table 4. The L31 genome was assembled into 67 contigs (ranging from 551 – 290,053 bp) forming one presumptive circular chromosome of 2,826,754 base pairs (46.73% GC content). A total of 2,749 ORFs were predicted: 2,687 are protein-coding genes, and 62 are RNA genes. A total of 2,173 (79.05%) protein-coding genes were assigned a putative function. The L34 genome was assembled into 51 contigs (ranging from 288 – 237,520 bp) forming a presumptive single circular chromosome of 2,937,717 base pairs (46.81% GC content). A total of 2,845 ORFs were predicted: 2,774 are protein-coding genes, and 71 are RNA genes. A total of 2,216 (77.89%) protein coding genes were assigned a putative function. Finally, the L35 genome was assembled into 51 contigs (687 – 226,797 bp) forming one presumptive chromosome of 2,937,403 base pairs (46.81%). A total of 2,842 ORFs were predicted: 2,772 are protein-coding genes, and 70 are RNA genes. A total of 2,217 (78.01%) protein coding genes were assigned a putative function.
Table 3

Nucleotide content and gene count level of the genomes

      L31     L34     L35
Attribute     Value      %agea     Value     %agea     Value     %agea
Genome Size (bp)     2,826,754      100     2,937,717     100     2,937,403     100
DNA G+C content (bp)     1,320,949      46.73     1,375,266     46.81     1,375,134     46.81
DNA coding region (bp)     2,422,731      85.71     2,519,202     85.75     2,517,453     85.70
Total genes     2,749      100     2,854     100     2,842     100
RNA genes     62      2.26     71     2.50     70     2.46
Protein-coding genes     2,687      97.74     2,774     97.50     2,772     97.54
Genes with functional prediction     2,173      79.05     2,216     77.89     2,217     78.01
Genes in paralog clusters     1,818      66.13     1,898     66.71     1,869     65.76
Genes assigned to COGs     2,121      77.16     2,150     75.57     2,151     75.69
Genes assigned to KOGs     886      32.23     913     32.09     914     32.16
Genes assigned to Pfam     2,209      80.36     2,250     79.09     2,254     79.31
Genes assigned to TIGRfam     880      31.01     893     31.39     892     31.39
Genes with signal peptides     138      5.02     139     4.89     138     4.86
Genes with transmembrane helices     813      29.57     835     29.35     834     29.35

a) The total is based on either the size of the genome in base pairs or the total number of protein coding genes in the annotated genome.

Table 4

Number of genes associated with the 25 general COG functional categories

      L31       L34      L35
Code      Value      %agea      Value       %agea       Value      %agea       Description
J      150      6.56      150       6.49       150      6.48       Translation
A      -      -      -       -       -      -       RNA processing and modification
K      203      8.88      206       8.91       207      8.95       Transcription
L      123      5.38      132       5.71       134      5.79       Replication, recombination and repair
B      -      -      -       -       -      -       Chromatin structure and dynamics
D      33      1.44      29       1.25       29      1.25       Cell cycle control, mitosis and meiosis
Y      -      -      -       -       -      -       Nuclear structure
V      75      3.28      79       3.42       79      3.41       Defense mechanisms
T      82      3.59      84       3.63       85      3.67       Signal transduction mechanisms
M      129      5.65      128       5.54       127      5.49       Cell wall/membrane biogenesis
N      9      0.39      8       0.35       8      0.35       Cell motility
Z      -      -      -       -       -      -       Cytoskeleton
W      -      -      -       -       -      -       Extracellular structures
U      28      1.23      23       0.99       23      0.99       Intracellular trafficking and secretion
O      59      2.58      59       2.55       59      2.5       Posttranslational modification, protein turnover, chaperones
C      90      3.94      87       3.76       88      3.80       Energy production and conversion
G      303      13.26      315       13.62       315      13.61       Carbohydrate transport and metabolism
E      183      8.01      178       7.70       177      7.65       Amino acid transport and metabolism
F      87      3.81      85       3.68       85      3.67       Nucleotide transport and metabolism
H      58      2.54      60       2.60       60      2.59       Coenzyme transport and metabolism
I      55      2.41      57       2.47       57      2.46       Lipid transport and metabolism
P      96      4.20      95       4.11       95      4.11       Inorganic ion transport and metabolism
Q      21      0.92      21       0.91       21      0.91       Secondary metabolites biosynthesis, transport and catabolism
R      285      12.47      292       12.63       291      12.58       General function prediction only
S      216      9.45      224       9.69       224      9.68       Function unknown
-      628      22.84      695       24.43       691      24.31       Not in COGs

a) The total is based on the total number of protein coding genes in the annotated genome.

a) The total is based on either the size of the genome in base pairs or the total number of protein coding genes in the annotated genome. a) The total is based on the total number of protein coding genes in the annotated genome.

Comparison with strain GG

The beneficial effects of human-intestinal derived GG have been studied for two decades [42-45] and its complete genome is available in NCBI [46]. We have compared the draft genome sequences of the potential probiotic strains L31, L34, and L35 to GG. The GG genome (3,010,111 bp, 46.69% GC content) is slightly larger than the new genomes presented here, and has approximately the same GC content (Table 3). In a recent comparative genomics study of 100 strains, Douillard, et al. [47] delineated seventeen variable chromosomal regions of strain GG (annotated in Figure 3), and the majority of these regions are absent or incomplete in the genomes of strains L31, L34, and L35 (Figure 3), notably the spaCBA pili gene cluster required for mucus adhesion [46]. The galactitol PTS region important for dulcitol utilization, a trait that typically belongs to isolates adapted to the intestinal tract [47], is conserved in L31, L34, and L35. Similar to GG, L31, L34, and L35 each contain genes annotated as L-lactate dehydrogenase (ldhL) and D-lactate dehydrogenase (ldhD) important for synthesizing L-lactate and D-lactate from pyruvate, respectively [49]. GG is unable to metabolize either maltose due to an inserted gene between the maltose-specific transport genes and hydrolase, or lactose because of a 38 bp N-terminal truncation in lacT and a disrupted lacG [47,50]. Strains L31, L34, and L35 all have an intact maltose locus and carry non-mutated copies of lacT and lacG (locations indicated on Figure 3), and therefore are predicted to utilize both maltose and lactose.
Figure 3

Circular representation of 3 draft genomes compared against strain GG (NC_ 013198). The innermost rings show GC content (black) and GC skew (purple/green). The remaining rings show BLASTn results of each genome against GG with results rendered using the BRIG program [48]. Relative shading density (from darker to lighter) within each circle represents levels of nucleotide homology. Blank regions represent absent genetic regions. Genetic regions of interest are annotated on the outermost ring. Numbered elements (1-17) represent the previously identified variable chromosomal regions of GG [47].

Circular representation of 3 draft genomes compared against strain GG (NC_ 013198). The innermost rings show GC content (black) and GC skew (purple/green). The remaining rings show BLASTn results of each genome against GG with results rendered using the BRIG program [48]. Relative shading density (from darker to lighter) within each circle represents levels of nucleotide homology. Blank regions represent absent genetic regions. Genetic regions of interest are annotated on the outermost ring. Numbered elements (1-17) represent the previously identified variable chromosomal regions of GG [47]. In line with the anti-inflammatory phenotypic differences already noted [9,29], differences in genomic features between L31 and the two isolates, L34 and L35, can also be made relative to strain GG. The taurine transport system deemed important for bile resistance as well as the fucU, fucI, fcsR, and α-L-fucosidase genes required for metabolizing fucosylated compounds present in gastrointestinal environments are found in L34 and L35 genomes, but not in L31. GG, despite belonging to a species known for rhamnose utilization, possesses an altered rhamnose locus and cannot utilize rhamnose [46]. L31 contains an intact rhamnose locus, while this locus in strains L34 and L35 looks similarly disrupted to that of strain GG. It is also noteworthy that L31 contains an iron-transport and a general secretion system not present in strains L34, L35, or GG.

Conclusion

Here we have presented the draft genomes of three potential probiotic strains of : L31, L34, and L35. Brief genome comparisons indicate that strains L34 and L35 are most similar to GG, while L31 contains marked differences suggesting it may have originated from a slightly different ecological niche [47]. L34 and L35 were isolated from the same host based on initial distinguishing colony morphology [9], however current colony morphology for these strains is not unique (Figure 2) and comparison of the draft genomes suggests the two genomes are nearly identical and similarly distinct from L31. It is possible that L34 and L35 may represent isolates of the same strain. Future studies will combine functional data with genomics, which is a powerful method for not only validating probiotic features of beneficial microbes, but also for learning about the environmental adaptations that have favored their mutual relationship with human hosts.
  36 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

2.  GenePRIMP: a gene prediction improvement pipeline for prokaryotic genomes.

Authors:  Amrita Pati; Natalia N Ivanova; Natalia Mikhailova; Galina Ovchinnikova; Sean D Hooper; Athanasios Lykidis; Nikos C Kyrpides
Journal:  Nat Methods       Date:  2010-05-02       Impact factor: 28.547

Review 3.  Probiotics in the management of children with allergy and other disorders of intestinal inflammation.

Authors:  J A Vanderhoof; S H Mitmesser
Journal:  Benef Microbes       Date:  2010-11       Impact factor: 4.205

Review 4.  Probiotic and other functional microbes: from markets to mechanisms.

Authors:  Maija Saxelin; Soile Tynkkynen; Tiina Mattila-Sandholm; Willem M de Vos
Journal:  Curr Opin Biotechnol       Date:  2005-04       Impact factor: 9.740

Review 5.  Taxonomy of Lactobacilli and Bifidobacteria.

Authors:  Giovanna E Felis; Franco Dellaglio
Journal:  Curr Issues Intest Microbiol       Date:  2007-09

6.  The Families and Genera of the Bacteria: Preliminary Report of the Committee of the Society of American Bacteriologists on Characterization and Classification of Bacterial Types.

Authors:  C E Winslow; J Broadhurst; R E Buchanan; C Krumwiede; L A Rogers; G H Smith
Journal:  J Bacteriol       Date:  1917-09       Impact factor: 3.490

7.  List of Bacterial Names with Standing in Nomenclature: a folder available on the Internet.

Authors:  J P Euzéby
Journal:  Int J Syst Bacteriol       Date:  1997-04

8.  Lactobacillus nasuensis sp. nov., a lactic acid bacterium isolated from silage, and emended description of the genus Lactobacillus.

Authors:  Yimin Cai; Huili Pang; Maki Kitahara; Moriya Ohkuma
Journal:  Int J Syst Evol Microbiol       Date:  2011-07-01       Impact factor: 2.747

9.  Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism.

Authors:  Jeremy Andrew Peña; James Versalovic
Journal:  Cell Microbiol       Date:  2003-04       Impact factor: 3.715

10.  The Genomes On Line Database (GOLD) in 2009: status of genomic and metagenomic projects and their associated metadata.

Authors:  Konstantinos Liolios; I-Min A Chen; Konstantinos Mavromatis; Nektarios Tavernarakis; Philip Hugenholtz; Victor M Markowitz; Nikos C Kyrpides
Journal:  Nucleic Acids Res       Date:  2009-11-13       Impact factor: 16.971

View more
  3 in total

1.  Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells.

Authors:  Prapaporn Boonma; Jennifer K Spinler; Susan F Venable; James Versalovic; Somying Tumwasorn
Journal:  BMC Microbiol       Date:  2014-07-02       Impact factor: 3.605

2.  Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by Candida Administration through a Synergy of Uremic Toxin, Lipopolysaccharide, and (1➔3)-β-D-Glucan, but Is Attenuated by Lacticaseibacillus rhamnosus L34.

Authors:  Somkanya Tungsanga; Wimonrat Panpetch; Thansita Bhunyakarnjanarat; Kanyarat Udompornpitak; Pisut Katavetin; Wiwat Chancharoenthana; Piraya Chatthanathon; Naraporn Somboonna; Kriang Tungsanga; Somying Tumwasorn; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

3.  Intra-species variation within Lactobacillus rhamnosus correlates to beneficial or harmful outcomes: lessons from the oral cavity.

Authors:  Mangala A Nadkarni; Nandan P Deshpande; Marc R Wilkins; Neil Hunter
Journal:  BMC Genomics       Date:  2020-09-24       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.